London — As part of Marken’s continued expansion of services in the APAC region, the company announced the relocation and expansion of its Singapore office to further support clients’ needs for specialty logistics services. This expansion incorporates a new directly owned, purpose-built Singapore depot to support growing customer demand for investigational medical product distribution.
The new GMP-compliant facility will enable clients to leverage Marken’s global expertise in Life Science logistics while adding key Life Science specialty services for their programs in the Asia Pacific and Middle East regions. In a recent presentation to Marken employees, Gerard Barba, CEO of Marken announced, "The opening of our directly owned depot in Singapore sets the cornerstone of an expanding global network of GMP compliant distribution centers for Marken."
The new 14,500 sq. ft. Clinical Trial Supply Depot offers the full range of secured storage conditions including, secured controlled drug (ambient); 15 – 25C (controlled ambient); -2 to -8C (cold storage); -20C (frozen); -80C (deep frozen)
Clinical trial logistics services offered:
- Storage and distribution
- Drug returns and destruction
- Kit building
- Biological specimen storage in ultra low freezers – short and long term
In delivering specialty logistics services to the Asia Pacific market, Marken draws upon more than 30 years of experience in providing premium transportation and Life Science logistics services worldwide. The expanded Marken office in Singapore provides Life Science material logistics and Clinical Trial Supply management for Pharmaceutical and Biotech customers throughout the Asia Pacific region. This represents Marken’s latest investment in the region, which in 2010 saw the opening of a new office in Tokyo.
SOURCE: Marken
